{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:51Z","timestamp":1787020191013,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Guillain-Barre Syndrome (GBS), also known as acute idiopathic polyneuritis, is a critical acquired condition associated with preceding nonspecific infection or triggering factors like trauma, surgery, or vaccination. GBS is currently the most frequent cause of acute flaccid paralysis in India. This study evaluates the short-term and in-hospital outcomes in different subtypes of GBS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective observational study was conducted at V.S. Hospital, Ahmedabad, from September 2015 to December 2017. Patients above the age of 12 were included. Patients having other underlying neurological conditions, as well as immunodeficiency disorders, were excluded. The patients were classified into different subtypes of GBS, and functional outcomes were recorded on admission and discharge according to Hughes Scoring System. All statistical analyses were performed by using SPSS software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 50 patients, 35 (70%) were males. The mean age was of 37.18 +\/\u2212\u200918.35\u2009years. 25 (50%) patients had a preceding infection. 88% of patients presented with cranial nerve (CN) involvement had a Hughes Score of &gt;\/= 3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0087). They had less improvement of Hughes Score on discharge (0.13 +\/\u2212\u20090.04) as compared to the patients without cranial nerve involvement (0.38 +\/\u2212\u20090.08) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008). Respiratory involvement was associated with a higher Hughes Score (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) on admission. 85% of patients diagnosed with an axonal subtype of GBS had a Hughes Score of &gt;\/= 3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.06) compared to 74% patients with demyelinating subtype. Axonal subtype required double period (11 +\/\u2212\u20092.34) to show improvement as compared to demyelinating subtype (6 +\/\u2212\u20091.2) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020). Irrespective of the subtypes, in two different treatment cohorts (PLEX vs IVIG), there was no difference in short term functional outcomes measured by improvement in the Hughes scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.89).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early cranial nerve and respiratory involvement in patients presenting with GBS are associated with poor outcomes warranting immediate critical care involvement. In our study, amongst all the subtypes, axonal had poor clinical outcomes. Further clinical trials on the Indian subpopulation will help us evaluate the impact of different treatment modalities on this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-022-02676-4","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T04:03:10Z","timestamp":1650600190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India"],"prefix":"10.1186","volume":"22","author":[{"given":"Priyank","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Kelaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinal","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al Omari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhara","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmgard","family":"Behlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"issue":"2","key":"2676_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.nrl.0000117821.35196.0b","volume":"10","author":"KH Levin","year":"2004","unstructured":"Levin KH. Variants and Mimics of Guillain Barr\u00e9 Syndrome. Neurologist. 2004;10(2):61\u201374. https:\/\/doi.org\/10.1097\/01.nrl.0000117821.35196.0b.","journal-title":"Neurologist."},{"issue":"7","key":"2676_CR2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/01.WNL.0000055091.96905.D0","volume":"60","author":"A Chio","year":"2003","unstructured":"Chio A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R. Guillain-Barre syndrome: A prospective, population-based incidence and outcome survey. Neurology. 2003;60(7):1146\u201350. https:\/\/doi.org\/10.1212\/01.WNL.0000055091.96905.D0.","journal-title":"Neurology."},{"issue":"s2","key":"2676_CR3","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1086\/513793","volume":"176","author":"RAC Hughes","year":"1997","unstructured":"Hughes RAC, Rees JH. Clinical and Epidemiologic Features of Guillain-Barr\u00e9 Syndrome. J Infect Dis. 1997;176(s2):S92\u20138. https:\/\/doi.org\/10.1086\/513793.","journal-title":"J Infect Dis"},{"issue":"1 S","key":"2676_CR4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1002\/ana.410270704","volume":"27","author":"M Alter","year":"1990","unstructured":"Alter M. The epidemiology of Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990;27(1 S):S7\u2013S12. https:\/\/doi.org\/10.1002\/ana.410270704.","journal-title":"Ann Neurol"},{"issue":"6","key":"2676_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","volume":"109","author":"TE Feasby","year":"1986","unstructured":"Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of guillain-barr\u00e9e polyneuropathy. Brain. 1986;109(6):1115\u201326. https:\/\/doi.org\/10.1093\/brain\/109.6.1115.","journal-title":"Brain."},{"issue":"11","key":"2676_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/08830738030180110501","volume":"18","author":"R Koul","year":"2003","unstructured":"Koul R, Chacko A, Ahmed R, Varghese T, Javed H, Al-Lamki Z. Ten-year prospective study (Clinical Spectrum) of childhood Guillain-Barr\u00e9 Syndrome in the Arabian Peninsula: comparison of outcome in patients in the pre\u2014 and post\u2014intravenous immunoglobulin eras. J Child Neurol. 2003;18(11):767\u201371. https:\/\/doi.org\/10.1177\/08830738030180110501.","journal-title":"J Child Neurol"},{"issue":"11","key":"2676_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/08830738030180110801","volume":"18","author":"MR Molinero","year":"2003","unstructured":"Molinero MR, Varon D, Holden KR, Sladky JT, Molina IB, Cleaves F. Epidemiology of Childhood Guillain-Barr\u00e9 Syndrome as a Cause of Acute Flaccid Paralysis in Honduras: 1989\u20141999. J Child Neurol. 2003;18(11):741\u20137. https:\/\/doi.org\/10.1177\/08830738030180110801.","journal-title":"J Child Neurol"},{"issue":"2","key":"2676_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/CND.0b013e31818e9510","volume":"10","author":"G Deepak","year":"2008","unstructured":"Deepak G, Muraleedharan N, Baheti NN, Sarma SP, Abraham K. Electrodiagnostic and Clinical Aspects of Guillain-Barr\u00e9 Syndrome: An Analysis of 142 Cases. J Clin Neuromuscul Dis. 2008;10(2):42\u201351. https:\/\/doi.org\/10.1097\/CND.0b013e31818e9510.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"2","key":"2676_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Guillain-Barr\u00e9 syndrome and variants. Neurol Clin. 2013;31(2):491\u2013510. https:\/\/doi.org\/10.1016\/j.ncl.2013.01.005.","journal-title":"Neurol Clin"},{"issue":"1","key":"2676_CR10","first-page":"65","volume":"10","author":"S Yildirim","year":"2016","unstructured":"Yildirim S, Adviye R, G\u00fcl HL, T\u00fcrk B\u00dc. Acute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report. Iran J child Neurol. 2016;10(1):65\u20139 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27057191.","journal-title":"Iran J child Neurol"},{"issue":"3","key":"2676_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1469-0691.2006.01636.x","volume":"13","author":"S Sinha","year":"2007","unstructured":"Sinha S, Prasad KN, Jain D, Pandey CM, Jha S, Pradhan S. Preceding infections and anti-ganglioside antibodies in patients with Guillain\u2013Barr\u00e9 syndrome: a single centre prospective case-control study. Clin Microbiol Infect. 2007;13(3):334\u20137. https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01636.x.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2676_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1600-0404.1986.tb03295.x","volume":"73","author":"U Kaur","year":"1986","unstructured":"Kaur U, Chopra JS, Prabhakar S, Radhakrishnan K, Rana S. Guillain-Barr\u00e9 syndrome. A clinical electrophysiological and biochemical study. Acta Neurol Scand. 1986;73(4):394\u2013402. https:\/\/doi.org\/10.1111\/j.1600-0404.1986.tb03295.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"2676_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1600-0404.1994.tb01665.x","volume":"89","author":"SK Gupta","year":"2009","unstructured":"Gupta SK, Taly AB, Suresh TG, Rao S, Nagaraja D. Acute idiopathic axonal neuropathy (AIAN): a clinical and electrophysiological observation. Acta Neurol Scand. 2009;89(3):220\u20134. https:\/\/doi.org\/10.1111\/j.1600-0404.1994.tb01665.x.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2676_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","volume":"86","author":"YA Rajabally","year":"2015","unstructured":"Rajabally YA, Durand M-C, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain\u2013Barr\u00e9 syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86(1):115\u20139. https:\/\/doi.org\/10.1136\/jnnp-2014-307815.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8093","key":"2676_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"312","author":"RAC Hughes","year":"1978","unstructured":"Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;312(8093):750\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(78)92644-2.","journal-title":"Lancet."},{"key":"2676_CR16","unstructured":"Nguyen TP, Taylor RS. Guillain Barre Syndrome; 2021. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30335287."},{"key":"2676_CR17","doi-asserted-by":"publisher","first-page":"Doc16","DOI":"10.3205\/000220","volume":"13","author":"SR Sudulagunta","year":"2015","unstructured":"Sudulagunta SR, Sodalagunta MB, Sepehrar M, et al. Guillain-Barr\u00e9 syndrome: clinical profile and management. Ger. Med Sci. 2015;13:Doc16. https:\/\/doi.org\/10.3205\/000220.","journal-title":"Med Sci"},{"key":"2676_CR18","doi-asserted-by":"publisher","unstructured":"Bhargava A, Banakar BF, Pujar GS, Khichar S. A study of Guillain\u2013Barr\u00e9 syndrome with reference to cranial neuropathy and its prognostic implication. J Neurosci Rural Pract. 2014;05(S 01):S043-S047. https:\/\/doi.org\/10.4103\/0976-3147.145200","DOI":"10.4103\/0976-3147.145200"},{"key":"2676_CR19","doi-asserted-by":"publisher","unstructured":"Kumar M. Guillain-Barr\u00e9 Syndrome: a clinical study of twenty children. J Clin Diagnostic Res. 2015. https:\/\/doi.org\/10.7860\/JCDR\/2015\/8344.5491.","DOI":"10.7860\/JCDR\/2015\/8344.5491"},{"issue":"01","key":"2676_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4236\/nm.2013.41004","volume":"04","author":"G Sharma","year":"2013","unstructured":"Sharma G, Sood S, Sharma S. Seasonal, Age & Gender Variation of Guillain Barre Syndrome in a Tertiary Referral Center in India. Neurosci Med. 2013;04(01):23\u20138. https:\/\/doi.org\/10.4236\/nm.2013.41004.","journal-title":"Neurosci Med"},{"issue":"2","key":"2676_CR21","first-page":"60","volume":"21","author":"A Borhani Haghighi","year":"2012","unstructured":"Borhani Haghighi A, Banihashemi MA, Zamiri N, et al. Seasonal variation of Guillain-Barr\u00e9 syndrome admission in a large tertiary referral center in southern Iran: a 10 year analysis. Acta Neurol Taiwanica. 2012;21(2):60\u20133 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22879114.","journal-title":"Acta Neurol Taiwanica"},{"issue":"2","key":"2676_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1600-0404.2004.00272.x","volume":"110","author":"G Bogliun","year":"2004","unstructured":"Bogliun G, Beghi E. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110(2):100\u20136. https:\/\/doi.org\/10.1111\/j.1600-0404.2004.00272.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"2676_CR23","first-page":"168","volume":"61","author":"SV Dhadke","year":"2013","unstructured":"Dhadke SV, Dhadke VN, Bangar SS, Korade MB. Clinical profile of Guillain Barre syndrome. J Assoc Physicians India. 2013;61(3):168\u201372 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24475678.","journal-title":"J Assoc Physicians India"},{"issue":"Pt 1","key":"2676_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33\u201343. https:\/\/doi.org\/10.1093\/brain\/awt285.","journal-title":"Brain."},{"key":"2676_CR25","unstructured":"Daroff RB, Bradley WG. Bradley's neurology in clinical practice. Philadelphia: Elsevier\/Saunders; 2012."},{"key":"2676_CR26","doi-asserted-by":"publisher","unstructured":"Susuki K, Yuki N. Effect of methylprednisolone in patients with Guillain-Barr\u00e9 syndrome. Lancet (London, England). 2004;363(9416):1236\u20131237; author reply 1237-8. https:\/\/doi.org\/10.1016\/S0140-6736(04)15962-X.","DOI":"10.1016\/S0140-6736(04)15962-X"},{"issue":"3B","key":"2676_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1590\/S0004-282X2005000500010","volume":"63","author":"MC Fran\u00e7a","year":"2005","unstructured":"Fran\u00e7a MC, Deus-Silva L, de Castro R, et al. Guillain-Barr\u00e9 syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features. Arq Neuropsiquiatr. 2005;63(3B):772\u20135. https:\/\/doi.org\/10.1590\/S0004-282X2005000500010.","journal-title":"Arq Neuropsiquiatr"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02676-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02676-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02676-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T04:03:49Z","timestamp":1650600229000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02676-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2676"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02676-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects and\/or their legal guardian (s). All methods were carried out in accordance with relevant guidelines and regulations (declaration of Helsinki). All experimental protocols were approved by NHL municipal Medical College IRB at V.S. Hospital, Ahmedabad.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}